Preserve your records, and 2. Pack your bags.” Next, Americans can expect Mr. Kennedy to add a federal firewall that ...

Shyra Gardai, chief scientific officer at the molecular glue start-up EpiBiologics, says Big Pharma’s recent interest in glue ...

"The FDA's approval of Lumryz was not arbitrary or capricious," U.S. District Judge Amit P. Mehta wrote in a memorandum ...

AbbVie’s deal flop and NFL high-profile draft busts have a lot in common.

One of the most remarkable aspects of the populist alliance between Robert F. Kennedy Jr. and Donald Trump is that it puts ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

As 2024 ushers in political change, one of the most contentious issues bubbling beneath the surface is public health — notably, the role of addictive substances ...

Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most ...

I have spent my career fighting for the hardworking people of our state—especially those who need our support the most.

Sen. Baldwin says opponent Hovde “opposes efforts to negotiate with the big pharmaceutical companies to lower the price of ...

NextCure is going all in on its preclinical B7-H4-directed antibody-drug conjugate (ADC). | NextCure is going all in on its ...